Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 546


A Cohort Analysis of Clinical and Ultrasound Variables Predicting Cancer Risk in 20,001 Consecutive Thyroid Nodules.

Angell TE, Maurer R, Wang Z, Kim MI, Alexander CA, Barletta JA, Benson CB, Cibas ES, Cho NL, Doherty GM, Doubilet PM, Frates MC, Gawande AA, Krane JF, Marqusee E, Moore FD, Nehs MA, Larsen PR, Alexander EK.

J Clin Endocrinol Metab. 2019 Nov 1;104(11):5665-5672. doi: 10.1210/jc.2019-00664.


Differences in Thyroid Nodule Cytology and Malignancy Risk Between Children and Adults.

Cherella CE, Angell TE, Richman DM, Frates MC, Benson CB, Moore FD, Barletta JA, Hollowell M, Smith JR, Alexander EK, Cibas ES, Wassner AJ.

Thyroid. 2019 Aug;29(8):1097-1104. doi: 10.1089/thy.2018.0728.


The Posterior Adiposity Index: A Quantitative Selection Tool for Adrenalectomy Approach.

Lindeman B, Gawande AA, Moore FD Jr, Cho NL, Doherty GM, Nehs MA.

J Surg Res. 2019 Jan;233:26-31. doi: 10.1016/j.jss.2018.07.003. Epub 2018 Jul 26.


Effect of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Malignancy Rates in Thyroid Nodules: How to Counsel Patients on Extent of Surgery.

Lindeman BM, Nehs MA, Angell TE, Alexander EK, Gawande AA, Moore FD Jr, Doherty GM, Cho NL.

Ann Surg Oncol. 2019 Jan;26(1):93-97. doi: 10.1245/s10434-018-6932-5. Epub 2018 Oct 19.


Quantitative Analysis of the Benefits and Risk of Thyroid Nodule Evaluation in Patients ≥70 Years Old.

Wang Z, Vyas CM, Van Benschoten O, Nehs MA, Moore FD Jr, Marqusee E, Krane JF, Kim MI, Heller HT, Gawande AA, Frates MC, Doubilet PM, Doherty GM, Cho NL, Cibas ES, Benson CB, Barletta JA, Zavacki AM, Larsen PR, Alexander EK, Angell TE.

Thyroid. 2018 Apr;28(4):465-471. doi: 10.1089/thy.2017.0655. Epub 2018 Apr 2.


Reasons Associated with Total Thyroidectomy as Initial Surgical Management of an Indeterminate Thyroid Nodule.

Angell TE, Vyas CM, Barletta JA, Cibas ES, Cho NL, Doherty GM, Gawande AA, Howitt BE, Krane JF, Marqusee E, Strickland KC, Alexander EK, Moore FD Jr, Nehs MA.

Ann Surg Oncol. 2018 May;25(5):1410-1417. doi: 10.1245/s10434-018-6421-x. Epub 2018 Mar 8.


4D-CT is Superior to Ultrasound and Sestamibi for Localizing Recurrent Parathyroid Disease.

Hamidi M, Sullivan M, Hunter G, Hamberg L, Cho NL, Gawande AA, Doherty GM, Moore FD Jr, Nehs MA.

Ann Surg Oncol. 2018 May;25(5):1403-1409. doi: 10.1245/s10434-018-6367-z. Epub 2018 Feb 26.


Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study.

Hanna GJ, Busaidy NL, Chau NG, Wirth LJ, Barletta JA, Calles A, Haddad RI, Kraft S, Cabanillas ME, Rabinowits G, O'Neill A, Limaye SA, Alexander EK, Moore FD Jr, Misiwkeiwicz K, Thomas T, Nehs M, Marqusee E, Lee SL, Jänne PA, Lorch JH.

Clin Cancer Res. 2018 Apr 1;24(7):1546-1553. doi: 10.1158/1078-0432.CCR-17-2297. Epub 2018 Jan 4.


Differential Growth Rates of Benign vs. Malignant Thyroid Nodules.

Angell TE, Vyas CM, Medici M, Wang Z, Barletta JA, Benson CB, Cibas ES, Cho NL, Doherty GM, Doubilet PM, Frates MC, Gawande AA, Heller HT, Kim MI, Krane JF, Marqusee E, Moore FD Jr, Nehs MA, Zavacki AM, Larsen PR, Alexander EK.

J Clin Endocrinol Metab. 2017 Dec 1;102(12):4642-4647. doi: 10.1210/jc.2017-01832.


Prevalence of Contralateral Tumors in Patients with Follicular Variant of Papillary Thyroid Cancer.

Sullivan MC, Graham PH, Alexander EK, Ruan DT, Nehs MA, Gawande AA, Moore FD Jr, Howitt BE, Strickland KC, Krane JF, Barletta JA, Cho NL.

J Am Coll Surg. 2017 Jun;224(6):1021-1027. doi: 10.1016/j.jamcollsurg.2016.12.007. Epub 2016 Dec 23.


Blockade of IgM-Mediated Inflammation Alters Wound Progression in a Swine Model of Partial-Thickness Burn.

Sadeghipour H, Torabi R, Gottschall J, Lujan-Hernandez J, Sachs DH, Moore FD Jr, Cetrulo CL Jr.

J Burn Care Res. 2017 May/Jun;38(3):148-160. doi: 10.1097/BCR.0000000000000459.


Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid Cancer.

Gibson WJ, Ruan DT, Paulson VA, Barletta JA, Hanna GJ, Kraft S, Calles A, Nehs MA, Moore FD Jr, Taylor-Weiner A, Wala JA, Zack TI, Lee TC, Fennessy FM, Alexander EK, Thomas T, Janne PA, Garraway LA, Carter SL, Beroukhim R, Lorch JH, Van Allen EM.

Clin Cancer Res. 2017 May 1;23(9):2367-2373. doi: 10.1158/1078-0432.CCR-16-2154-T. Epub 2016 Oct 17.


Clinical, Sonographic, and Pathological Characteristics of RAS-Positive Versus BRAF-Positive Thyroid Carcinoma.

Kakarmath S, Heller HT, Alexander CA, Cibas ES, Krane JF, Barletta JA, Lindeman NI, Frates MC, Benson CB, Gawande AA, Cho NL, Nehs M, Moore FD, Marqusee E, Kim MI, Larsen PR, Kwong N, Angell TE, Alexander EK.

J Clin Endocrinol Metab. 2016 Dec;101(12):4938-4944. Epub 2016 Sep 30.


Features and Outcome of Autonomous Thyroid Nodules in Children: 31 Consecutive Patients Seen at a Single Center.

Ly S, Frates MC, Benson CB, Peters HE, Grant FD, Drubach LA, Voss SD, Feldman HA, Smith JR, Barletta J, Hollowell M, Cibas ES, Moore FD Jr, Modi B, Shamberger RC, Huang SA.

J Clin Endocrinol Metab. 2016 Oct;101(10):3856-3862. Epub 2016 Aug 8.


Prevention of intestinal ischemia-reperfusion injury in humanized mice.

Sheu EG, Wakatsuki K, Oakes S, Carroll MC, Moore FD Jr.

Surgery. 2016 Aug;160(2):436-42. doi: 10.1016/j.surg.2016.03.001. Epub 2016 Apr 15.


Identification of Novel Oncogenic Mutations in Thyroid Cancer.

Pitt SC, Hernandez RA, Nehs MA, Gawande AA, Moore FD Jr, Ruan DT, Cho NL.

J Am Coll Surg. 2016 Jun;222(6):1036-1043.e2. doi: 10.1016/j.jamcollsurg.2015.12.047. Epub 2016 Jan 14.


The variable phenotype and low-risk nature of RAS-positive thyroid nodules.

Medici M, Kwong N, Angell TE, Marqusee E, Kim MI, Frates MC, Benson CB, Cibas ES, Barletta JA, Krane JF, Ruan DT, Cho NL, Gawande AA, Moore FD Jr, Alexander EK.

BMC Med. 2015 Aug 7;13:184. doi: 10.1186/s12916-015-0419-z.


Primary hyperparathyroidism after Roux-en-Y gastric bypass.

Chen Y, Lubitz CC, Shikora SA, Hodin RA, Gaz RD, Moore FD Jr, McKenzie TJ.

Obes Surg. 2015 Apr;25(4):700-4. doi: 10.1007/s11695-014-1444-2.


False negative cytology in large thyroid nodules.

Giles WH, Maclellan RA, Gawande AA, Ruan DT, Alexander EK, Moore FD Jr, Cho NL.

Ann Surg Oncol. 2015 Jan;22(1):152-7. doi: 10.1245/s10434-014-3952-7. Epub 2014 Jul 30.


Invited commentary.

Moore FD Jr.

J Am Coll Surg. 2014 Jun;218(6):1237-8. doi: 10.1016/j.jamcollsurg.2014.03.015. No abstract available.


How are childhood thyroid nodules discovered: opportunities for improving early detection.

Gupta A, Ly S, Castroneves LA, Frates MC, Benson CB, Feldman HA, Wassner AJ, Smith JR, Marqusee E, Alexander EK, Barletta J, Muyide F, Doubilet PM, Peters HE, Webb S, Modi BP, Paltiel HJ, Martins Y, Burmeister K, Kozakewich H, Hollowell M, Cibas ES, Moore FD Jr, Shamberger RC, Larsen PR, Huang SA.

J Pediatr. 2014 Mar;164(3):658-60. doi: 10.1016/j.jpeds.2013.10.090. Epub 2013 Dec 15.


Surgeons and patients disagree on the potential consequences from hypoparathyroidism.

Cho NL, Moalem J, Chen L, Lubitz CC, Moore FD Jr, Ruan DT.

Endocr Pract. 2014 May;20(5):427-46. doi: 10.4158/EP13321.OR.


Recalcitrant hypocalcemia after thyroidectomy in patients with previous Roux-en-Y gastric bypass.

McKenzie TJ, Chen Y, Hodin RA, Shikora SA, Hutter MM, Gaz RD, Moore FD Jr, Lubitz CC.

Surgery. 2013 Dec;154(6):1300-6; discussion 1306. doi: 10.1016/j.surg.2013.04.031. Epub 2013 Aug 23.


A standardized assessment of thyroid nodules in children confirms higher cancer prevalence than in adults.

Gupta A, Ly S, Castroneves LA, Frates MC, Benson CB, Feldman HA, Wassner AJ, Smith JR, Marqusee E, Alexander EK, Barletta J, Doubilet PM, Peters HE, Webb S, Modi BP, Paltiel HJ, Kozakewich H, Cibas ES, Moore FD Jr, Shamberger RC, Larsen PR, Huang SA.

J Clin Endocrinol Metab. 2013 Aug;98(8):3238-45. doi: 10.1210/jc.2013-1796. Epub 2013 Jun 4.


Bilateral neck exploration decreases operative time compared to minimally invasive parathyroidectomy in patients with discordant imaging.

Nehs MA, Ruan DT, Gawande AA, Moore FD Jr, Cho NL.

World J Surg. 2013 Jul;37(7):1614-7. doi: 10.1007/s00268-013-2007-8.


Thyroid nodule size and prediction of cancer.

Kamran SC, Marqusee E, Kim MI, Frates MC, Ritner J, Peters H, Benson CB, Doubilet PM, Cibas ES, Barletta J, Cho N, Gawande A, Ruan D, Moore FD Jr, Pou K, Larsen PR, Alexander EK.

J Clin Endocrinol Metab. 2013 Feb;98(2):564-70. doi: 10.1210/jc.2012-2968. Epub 2012 Dec 28.


Global tyrosine kinome profiling of human thyroid tumors identifies Src as a promising target for invasive cancers.

Cho NL, Lin CI, Du J, Whang EE, Ito H, Moore FD Jr, Ruan DT.

Biochem Biophys Res Commun. 2012 May 11;421(3):508-13. doi: 10.1016/j.bbrc.2012.04.034. Epub 2012 Apr 10.


Bronchogenic cyst masquerading as an adrenal tumor: a case of mistaken identity.

O'Neal PB, Moore FD, Gawande A, Cho NL, King EE, Moalem J, Ruan D.

Endocr Pract. 2012 Sep-Oct;18(5):e102-5. doi: 10.4158/EP11186.CR. Review.


Hemorrhagic shock as the initial manifestation of pheochromocytoma: report of a sequential management strategy.

O'Neal PB, Moore FD Jr, Gawande A, Cho NL, Moalem J, Ruan DT.

Endocr Pract. 2012 Jul-Aug;18(4):e81-4. doi: 10.4158/EP11149.CR.


Thyroid-specific knockout of the tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-κB activity.

Lin CI, Barletta JA, Nehs MA, Morris ZS, Donner DB, Whang EE, Jeong JW, Kimura S, Moore FD Jr, Ruan DT.

Surgery. 2011 Dec;150(6):1295-302. doi: 10.1016/j.surg.2011.09.014.


Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.

Yip DT, Hassan M, Pazaitou-Panayiotou K, Ruan DT, Gawande AA, Gaz RD, Moore FD Jr, Hodin RA, Stephen AE, Sadow PM, Daniels GH, Randolph GW, Parangi S, Lubitz CC.

Surgery. 2011 Dec;150(6):1168-77. doi: 10.1016/j.surg.2011.09.043.


Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical cancers.

Nehs MA, Lin CI, Kozono DE, Whang EE, Cho NL, Zhu K, Moalem J, Moore FD Jr, Ruan DT.

Surgery. 2011 Dec;150(6):1032-9. doi: 10.1016/j.surg.2011.09.012.


Critical role of identification of the second gland during unilateral parathyroid surgery: a prospective review of 119 patients with concordant localization.

Cho NL, Gawande AA, Sheu EG, Moore FD Jr, Ruan DT.

Arch Surg. 2011 May;146(5):512-6. doi: 10.1001/archsurg.2011.91.


Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer.

Lin CI, Du J, Shen WT, Whang EE, Donner DB, Griff N, He F, Moore FD Jr, Clark OH, Ruan DT.

J Clin Endocrinol Metab. 2011 Mar;96(3):E554-65. doi: 10.1210/jc.2010-1800. Epub 2010 Dec 29.


The predictive value of the fine-needle aspiration diagnosis "suspicious for a follicular neoplasm, hurthle cell type" in patients with hashimoto thyroiditis.

Roh MH, Jo VY, Stelow EB, Faquin WC, Zou KH, Alexander EK, Larsen PR, Marqusee E, Benson CB, Frates MC, Gawande A, Moore FD Jr, Cibas ES.

Am J Clin Pathol. 2011 Jan;135(1):139-45. doi: 10.1309/AJCP0RW2WMDUAKGK.


Accuracy of 4-dimensional computed tomography in poorly localized patients with primary hyperparathyroidism.

Lubitz CC, Hunter GJ, Hamberg LM, Parangi S, Ruan D, Gawande A, Gaz RD, Randolph GW, Moore FD Jr, Hodin RA, Stephen AE.

Surgery. 2010 Dec;148(6):1129-37; discussion 1137-8. doi: 10.1016/j.surg.2010.09.002.


The inflammatory response after an epidermal burn depends on the activities of mouse mast cell proteases 4 and 5.

Younan G, Suber F, Xing W, Shi T, Kunori Y, Abrink M, Pejler G, Schlenner SM, Rodewald HR, Moore FD Jr, Stevens RL, Adachi R, Austen KF, Gurish MF.

J Immunol. 2010 Dec 15;185(12):7681-90. doi: 10.4049/jimmunol.1002803. Epub 2010 Nov 12.


Autophagy induction with RAD001 enhances chemosensitivity and radiosensitivity through Met inhibition in papillary thyroid cancer.

Lin CI, Whang EE, Donner DB, Du J, Lorch J, He F, Jiang X, Price BD, Moore FD Jr, Ruan DT.

Mol Cancer Res. 2010 Sep;8(9):1217-26. doi: 10.1158/1541-7786.MCR-10-0162. Epub 2010 Aug 24.


Sulindac reverses aberrant expression and localization of beta-catenin in papillary thyroid cancer cells with the BRAFV600E mutation.

Cho NL, Lin CI, Whang EE, Carothers AM, Moore FD Jr, Ruan DT.

Thyroid. 2010 Jun;20(6):615-22. doi: 10.1089/thy.2009.0415.


Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction.

Haas MS, Alicot EM, Schuerpf F, Chiu I, Li J, Moore FD, Carroll MC.

Cardiovasc Res. 2010 Sep 1;87(4):618-27. doi: 10.1093/cvr/cvq141. Epub 2010 May 11.


Inhibition of rat gut reperfusion injury with an agent developed for the mouse. Evidence that amplification of injury by innate immunity is conserved between two animal species.

Afnan J, Ahmadi-Yazdi C, Sheu EG, Oakes SM, Moore FD Jr.

Am J Physiol Regul Integr Comp Physiol. 2010 Jun;298(6):R1675-81. doi: 10.1152/ajpregu.00380.2009. Epub 2010 Mar 24.


Career satisfaction of women in surgery: perceptions, factors, and strategies.

Ahmadiyeh N, Cho NL, Kellogg KC, Lipsitz SR, Moore FD Jr, Ashley SW, Zinner MJ, Breen EM.

J Am Coll Surg. 2010 Jan;210(1):23-8. doi: 10.1016/j.jamcollsurg.2009.08.011. Epub 2009 Oct 2.


Autophagy: a new target for advanced papillary thyroid cancer therapy.

Lin CI, Whang EE, Abramson MA, Jiang X, Price BD, Donner DB, Moore FD Jr, Ruan DT.

Surgery. 2009 Dec;146(6):1208-14. doi: 10.1016/j.surg.2009.09.019.


Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enhances both chemosensitivity and radiosensitivity in papillary thyroid cancer.

Lin CI, Whang EE, Donner DB, Jiang X, Price BD, Carothers AM, Delaine T, Leffler H, Nilsson UJ, Nose V, Moore FD Jr, Ruan DT.

Mol Cancer Res. 2009 Oct;7(10):1655-62. doi: 10.1158/1541-7786.MCR-09-0274. Epub 2009 Oct 13.


Restoration of skeletal muscle ischemia-reperfusion injury in humanized immunodeficient mice.

Sheu EG, Oakes SM, Ahmadi-Yazdi C, Afnan J, Carroll MC, Moore FD Jr.

Surgery. 2009 Aug;146(2):340-6. doi: 10.1016/j.surg.2009.06.010.


Improved survival of murine island skin flaps by prevention of reperfusion injury.

Tatlidede SH, Murphy AD, McCormack MC, Nguyen JT, Eberlin KR, Randolph MA, Moore FD Jr, Austen WG Jr.

Plast Reconstr Surg. 2009 May;123(5):1431-9. doi: 10.1097/PRS.0b013e3181a071e8.


Galectin-3 regulates apoptosis and doxorubicin chemoresistance in papillary thyroid cancer cells.

Lin CI, Whang EE, Abramson MA, Donner DB, Bertagnolli MM, Moore FD Jr, Ruan DT.

Biochem Biophys Res Commun. 2009 Feb 6;379(2):626-31. doi: 10.1016/j.bbrc.2008.12.153. Epub 2009 Jan 3.


Attenuation of the effects of rat hemorrhagic shock with a reperfusion injury-inhibiting agent specific to mice.

Ahmadi-Yazdi C, Williams B, Oakes S, Moore FD Jr.

Shock. 2009 Sep;32(3):295-301. doi: 10.1097/SHK.0b013e3181995e0c.


Surgery for hyperparathyroidism in image-negative patients.

Chan RK, Ruan DT, Gawande AA, Moore FD Jr.

Arch Surg. 2008 Apr;143(4):335-7. doi: 10.1001/archsurg.143.4.335.


Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation.

Yassa L, Cibas ES, Benson CB, Frates MC, Doubilet PM, Gawande AA, Moore FD Jr, Kim BW, Nosé V, Marqusee E, Larsen PR, Alexander EK.

Cancer. 2007 Dec 25;111(6):508-16.

Supplemental Content

Loading ...
Support Center